Literature DB >> 20676839

Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure.

Hisashi Kimura1, Shinya Hiramitsu, Kenji Miyagishima, Kazumasa Mori, Ryuji Yoda, Shigeru Kato, Yasuchika Kato, Shin-ichiro Morimoto, Hitoshi Hishida, Yukio Ozaki.   

Abstract

The purpose of this study is to investigate the effects of renal function and anemia on the outcome of chronic heart failure (CHF). We targeted 711 consecutive patients who were hospitalized at the Division of Cardiology of Fujita Health University Hospital during a 5-year period. The subjects were divided into four groups according to their estimated glomerular filtration rate (e-GFR) calculated using the Modification of Diet in Renal Disease (MDRD) formula. Intergroup comparisons were conducted for underlying heart diseases, clinical findings at the time of hospitalization, treatment, and outcome. Moreover, the patients were divided into two groups according to their serum hemoglobin concentration at the time of hospitalization, using 12.0 g/dl as the dividing point, to study the effects of anemia on the outcome. In the group with decreased renal function, the average age was higher, and ischemic heart disease and associated conditions such as hypertension and diabetes mellitus were observed in most of the patients. In addition, the rate of anemia development and the plasma B-type natriuretic peptide concentration were also high. The greater the deterioration in renal function, the poorer the outcome became (P < 0.0001). Chronic heart failure complicated by anemia showed an especially poor outcome (P < 0.0001). As this study showed that renal function and anemia significantly affected the outcome of CHF, it is clear that the preservation of renal function and the management of anemia are important in addition to the conventional treatments for CHF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676839     DOI: 10.1007/s00380-009-1201-y

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Anaemia and heart failure.

Authors:  A J S Coats
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

2.  Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Authors:  Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

Review 3.  The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?

Authors:  Donald S Silverberg; Dov Wexler; Adrian Iaina
Journal:  J Nephrol       Date:  2004 Nov-Dec       Impact factor: 3.902

4.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.

Authors:  Tamara B Horwich; Gregg C Fonarow; Michele A Hamilton; W Robb MacLellan; Jeff Borenstein
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

5.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Authors:  D S Silverberg; D Wexler; M Blum; G Keren; D Sheps; E Leibovitch; D Brosh; S Laniado; D Schwartz; T Yachnin; I Shapira; D Gavish; R Baruch; B Koifman; C Kaplan; S Steinbruch; A Iaina
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

Review 6.  Anemia in chronic kidney disease and congestive heart failure.

Authors:  D S Silverberg; D Wexler; B Blum; A Iaina
Journal:  Blood Purif       Date:  2003       Impact factor: 2.614

7.  Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes.

Authors:  Apostolos Karavidas; George Lazaros; Evangelos Matsakas; Dimitrios Farmakis; John Parissis; Ioannis A Paraskevaidis; Christos Michailidis; Dimitrios Avramidis; Achilleas Zacharoulis; Sophia Arapi; Andreas Kaoukis; Apostolos Zacharoulis
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

8.  The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events.

Authors:  Hirofumi Ueno; Masafumi Nakayama; Sunao Kojima; Kenichi Kusuhara; Yasuhiro Nagayoshi; Megumi Yamamuro; Tsunenori Nishijima; Hiroki Usuku; Kouichi Kaikita; Hitoshi Sumida; Hiroshige Yamabe; Seigo Sugiyama; Michihiro Yoshimura; Hisao Ogawa
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

View more
  8 in total

1.  Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients.

Authors:  Yuya Matsue; Akihiko Matsumura; Masami Abe; Maki Ono; Mie Seya; Tomofumi Nakamura; Ryota Iwatsuka; Akira Mizukami; Masahiko Setoguchi; Wataru Nagahori; Masakazu Ohno; Makoto Suzuki; Yuji Hashimoto
Journal:  Heart Vessels       Date:  2011-12-10       Impact factor: 2.037

2.  A prognostic index for risk stratification for acute heart failure and death in subjects with ischemic cardiomyopathy and cardiac defibrillator.

Authors:  Lanfranco Antonini; Cristina Mollica; Antonio Auriti; Christian Pristipino; Vincenzo Pasceri; Francesca Leone; Salvatore Greco
Journal:  Heart Vessels       Date:  2015-05       Impact factor: 2.037

3.  Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention.

Authors:  Manabu Ogita; Kenichi Sakakura; Tomohiro Nakamura; Hiroshi Funayama; Hiroshi Wada; Ryo Naito; Yoshitaka Sugawara; Norifumi Kubo; Junya Ako; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2011-08-06       Impact factor: 2.037

4.  Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome.

Authors:  Sylvestre Maréchaux; Stéphanie Barrailler; Claire Pinçon; Vincent Decourcelle; Thomas Guidez; Sophie Braun; Nadia Bouabdallaoui; Jean-Jacques Bauchart; Jean Luc Auffray; Francis Juthier; Carlo Banfi; Sophie Susen; Brigitte Jude; Philippe Asseman; Eric Van Belle; Pierre Vladimir Ennezat
Journal:  Heart Vessels       Date:  2011-05-12       Impact factor: 2.037

5.  Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases.

Authors:  Tomokazu Ikemoto; Yukihiro Hojo; Hideyuki Kondo; Nozomu Takahashi; Masahiro Hirose; Yoshioki Nishimura; Takaaki Katsuki; Kazuyuki Shimada; Kazuomi Kario
Journal:  Heart Vessels       Date:  2011-06-11       Impact factor: 2.037

6.  Acidic urine is associated with poor prognosis in patients with chronic heart failure.

Authors:  Yoichiro Otaki; Tetsu Watanabe; Hiroki Takahashi; Hiromasa Hasegawa; Shintaro Honda; Akira Funayama; Shunsuke Netsu; Mitsunori Ishino; Takanori Arimoto; Tetsuro Shishido; Takehiko Miyashita; Takuya Miyamoto; Tsuneo Konta; Isao Kubota
Journal:  Heart Vessels       Date:  2012-12-30       Impact factor: 2.037

7.  Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study.

Authors:  Zhi-Qiang Hou; Zhao-Xia Sun; Chong-Yi Su; Hui Tan; Xia Zhong; Bo Hu; Yi Zhou; De-Ya Shang
Journal:  Heart Vessels       Date:  2012-09-23       Impact factor: 2.037

8.  Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis.

Authors:  Midori Hasegawa; Junichi Ishii; Fumihiko Kitagawa; Kyoko Kanayama; Hiroshi Takahashi; Yukio Ozaki; Yukio Yuzawa
Journal:  Heart Vessels       Date:  2012-08-23       Impact factor: 2.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.